Use of CA125 and HE4 serum markers to predict ovarian cancer in elevated-risk women
- Beth Y. Karlan
- , Jason Thorpe
- , Kate Watabayashi
- , Charles W. Drescher
- , Melanie Palomares
- , Mary B. Daly
- , Pam Paley
- , Paula Hillard
- , M. Robyn Andersen
- , Garnet Anderson
- , Ronny Drapkin
- , Nicole Urban
- Cedars-Sinai Medical Center
- Fred Hutchinson Cancer Research Center
- Pacific Gynecology Specialists
- City of Hope National Medical Center
- Stanford University
- Dana-Farber Cancer Institute
Research output: Contribution to journal › Article › peer-review
28
Scopus
citations